![l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease - Billings - 2019 - Journal of Neurochemistry - Wiley ... l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease - Billings - 2019 - Journal of Neurochemistry - Wiley ...](https://onlinelibrary.wiley.com/cms/asset/1505e313-7f2f-4dc5-bf52-ab765534bfde/jnc14676-fig-0010-m.png)
l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease - Billings - 2019 - Journal of Neurochemistry - Wiley ...
![Iron, Dopamine, and α-Synuclein Interactions in at-Risk Dopaminergic Neurons in Parkinson's Disease | Neuroscience Bulletin Iron, Dopamine, and α-Synuclein Interactions in at-Risk Dopaminergic Neurons in Parkinson's Disease | Neuroscience Bulletin](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12264-018-0209-7/MediaObjects/12264_2018_209_Fig1_HTML.gif)
Iron, Dopamine, and α-Synuclein Interactions in at-Risk Dopaminergic Neurons in Parkinson's Disease | Neuroscience Bulletin
![Iron Involvement in Dopamine Oxidation and Neuromelanin synthesis. The... | Download Scientific Diagram Iron Involvement in Dopamine Oxidation and Neuromelanin synthesis. The... | Download Scientific Diagram](https://www.researchgate.net/publication/358774363/figure/fig1/AS:1127556245913601@1645841766130/Iron-Involvement-in-Dopamine-Oxidation-and-Neuromelanin-synthesis-The-hydroxyl-groups-of.png)
Iron Involvement in Dopamine Oxidation and Neuromelanin synthesis. The... | Download Scientific Diagram
![4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN | EMBO Molecular Medicine 4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN | EMBO Molecular Medicine](https://www.embopress.org/cms/10.15252/emmm.201910489/asset/cf5be368-e1cc-45bb-a6cb-6686f3e85005/assets/graphic/emmm201910489-abs-0001-m.png)
4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN | EMBO Molecular Medicine
![Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e78a42aa41a12fc89d4bc4d359d026a71e09b232/12-Figure4-1.png)
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar
![Zinc antagonizes iron-regulation of tyrosine hydroxylase activity and dopamine production in Drosophila melanogaster | BMC Biology | Full Text Zinc antagonizes iron-regulation of tyrosine hydroxylase activity and dopamine production in Drosophila melanogaster | BMC Biology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12915-021-01168-0/MediaObjects/12915_2021_1168_Fig8_HTML.png)
Zinc antagonizes iron-regulation of tyrosine hydroxylase activity and dopamine production in Drosophila melanogaster | BMC Biology | Full Text
![Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e78a42aa41a12fc89d4bc4d359d026a71e09b232/5-Figure2-1.png)
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease | Semantic Scholar
![Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson's disease | Acta Pharmacologica Sinica Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson's disease | Acta Pharmacologica Sinica](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41401-020-00555-7/MediaObjects/41401_2020_555_Fig1_HTML.png)
Beyond iron deposition: making sense of the latest evidence on ferroptosis in Parkinson's disease | Acta Pharmacologica Sinica
JoyScore - Dopamine, a neurotransmitter, is an important chemical in the brain that has many functions. It is involved in reward, motivation, memory, attention, and even regulation of body movements. The right
![Brain on X: "Iron and dopamine - a toxic couple. New Update article: https://t.co/RBAqqLv1Mj https://t.co/vFteXPJxDX" / X Brain on X: "Iron and dopamine - a toxic couple. New Update article: https://t.co/RBAqqLv1Mj https://t.co/vFteXPJxDX" / X](https://pbs.twimg.com/media/CdSPsQWWIAAlso_.jpg)
Brain on X: "Iron and dopamine - a toxic couple. New Update article: https://t.co/RBAqqLv1Mj https://t.co/vFteXPJxDX" / X
Effect of release of dopamine on iron transformations and reactive oxygen species (ROS) generation under conditions typical of coastal waters - Environmental Science: Processes & Impacts (RSC Publishing)
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders. - Munich Cluster for Systems Neurology - LMU Munich
![IJMS | Free Full-Text | Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease IJMS | Free Full-Text | Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease](https://www.mdpi.com/ijms/ijms-23-13678/article_deploy/html/images/ijms-23-13678-g001-550.jpg)
IJMS | Free Full-Text | Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
![Frontiers | New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease Frontiers | New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease](https://www.frontiersin.org/files/Articles/334035/fnmol-10-00455-HTML/image_m/fnmol-10-00455-g001.jpg)
Frontiers | New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease
![Functional neuroimaging of dopamine, iron, and opiates in restless legs syndrome (Chapter 47) - Neuroimaging of Sleep and Sleep Disorders Functional neuroimaging of dopamine, iron, and opiates in restless legs syndrome (Chapter 47) - Neuroimaging of Sleep and Sleep Disorders](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:94026:20160429112215011-0803:01863fig47_1.png?pub-status=live)
Functional neuroimaging of dopamine, iron, and opiates in restless legs syndrome (Chapter 47) - Neuroimaging of Sleep and Sleep Disorders
![Frontiers | Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease Frontiers | Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease](https://www.frontiersin.org/files/Articles/417568/fnins-12-00859-HTML/image_m/fnins-12-00859-g007.jpg)
Frontiers | Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease
Dopamine as A Robust Anchor to Immobilize Functional Molecules on the Iron Oxide Shell of Magnetic Nanoparticles | Journal of the American Chemical Society
![Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's Disease | ACS Chemical Neuroscience Effectiveness of the Iron Chelator CN128 in Mitigating the Formation of Dopamine Oxidation Products Associated with the Progression of Parkinson's Disease | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00557/asset/images/medium/cn0c00557_0011.gif)